Capecitabine Tablet, Film Coated
Product Images NDC 70756-816
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Capecitabine (NDC 70756-816). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lifestar Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Capecitabine-02 (Capecitabine 02)
Figure1 (Figure1)
Figure2 (Figure2)
Fig:3 (Figure3new)
Figure5 (Figure5)
Rev150mg (Newcapecitabine Tablets 150 mg 1200024384 V00)
Rev500mg (Newrevcapecitabine Tablets 500 mg 1200024383 V00)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.